BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 9858126)

  • 41. Growth hormone responses during strenuous exercise: the role of GH-releasing hormone and GH-releasing peptide-2.
    Maas HCM ; de Vries WR; Maitimu I; Bol E; Bowers CY; Koppeschaar HP
    Med Sci Sports Exerc; 2000 Jul; 32(7):1226-32. PubMed ID: 10912886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of potentiation of cholinergic tone by pyridostigmine on the GH response to GHRH in elderly men.
    Coiro V; Volpi R; Bertoni P; Finzi G; Marcato A; Caiazza A; Colla R; Giacalone G; Rossi G; Chiodera P
    Gerontology; 1992; 38(4):217-22. PubMed ID: 1358762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome.
    Leal-Cerro A; Pumar A; Garcia-Garcia E; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):649-54. PubMed ID: 7828354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiation and neuroregulatory control of growth hormone secretion.
    Ogilvy-Stuart AL; Wallace WH; Shalet SM
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):163-8. PubMed ID: 7923820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of enhancement of endogenous cholinergic tone with pyridostigmine on the dose-response relationships of growth hormone (GH)-releasing hormone-induced GH secretion in normal subjects.
    Peñalva A; Muruais C; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1990 Feb; 70(2):324-7. PubMed ID: 2105328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of free fatty acids by acipimox enhances the growth hormone (GH) responses to GH-releasing peptide 2 in elderly men.
    Van Dam PS; Smid HE; de Vries WR; Niesink M; Bolscher E; Waasdorp EJ; Dieguez C; Casanueva FF; Koppeschaar HP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4706-11. PubMed ID: 11134132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: studies in dogs with the use of GH-releasing hormone and a GH-releasing peptide.
    Rigamonti AE; Cavallera G; Bonomo S; Deghenghi R; Locatelli V; Cella SG; Müller EE
    Eur J Endocrinol; 2001 Nov; 145(5):635-44. PubMed ID: 11720883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH.
    Ross RJ; Tsagarakis S; Grossman A; Nhagafoong L; Touzel RJ; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1987 Dec; 27(6):727-33. PubMed ID: 2901302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Robust growth hormone (GH) secretion in aged female rats co-administered GH-releasing hexapeptide (GHRP-6) and GH-releasing hormone (GHRH).
    Walker RF; Yang SW; Bercu BB
    Life Sci; 1991; 49(20):1499-504. PubMed ID: 1943453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
    Massoud AF; Hindmarsh PC; Matthews DR; Brook CG
    Clin Endocrinol (Oxf); 1996 May; 44(5):555-62. PubMed ID: 8762732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3',5'-monophosphate accumulation in rat primary pituitary cell culture.
    Cheng K; Chan WW; Barreto A; Convey EM; Smith RG
    Endocrinology; 1989 Jun; 124(6):2791-8. PubMed ID: 2541999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion.
    Muller AF; Janssen JA; Lamberts SW; Bidlingmaier M; Strasburger CJ; Hofland L; van der Lely AJ
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):461-7. PubMed ID: 11678828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus.
    Micić D; Macut D; Popović V; Kendereski A; Sumarac-Dumanović M; Zorić S; Dieguez C; Casanueva FF
    Metabolism; 1999 Apr; 48(4):525-30. PubMed ID: 10206449
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth hormone (GH) responses to the hexapeptide GH-releasing peptide and GH-releasing hormone (GHRH) in the cynomolgus macaque: evidence for non-GHRH-mediated responses.
    Malozowski S; Hao EH; Ren SG; Marin G; Liu L; Southers JL; Merriam GR
    J Clin Endocrinol Metab; 1991 Aug; 73(2):314-7. PubMed ID: 1856262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The in vitro effect of leptin on growth hormone secretion from primary cultured ovine somatotrophs.
    Chen C; Roh SG; Nie GY; Loneragan K; Xu RW; Ruan M; Clarke LJ; Goding JW; Gertler A
    Endocrine; 2001 Feb; 14(1):73-8. PubMed ID: 11322504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different growth hormone (GH) response to GH-releasing peptide and GH-releasing hormone in hyperthyroidism.
    Ramos-Dias JC; Pimentel-Filho F; Reis AF; Lengyel AM
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1343-6. PubMed ID: 8636330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth hormone (GH)-releasing peptide and GH releasing hormone stimulate GH release from subpopulations of somatotrophs in rats.
    Mitani M; Kaji H; Abe H; Chihara K
    J Neuroendocrinol; 1996 Nov; 8(11):825-30. PubMed ID: 8933359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
    Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Awouters M; Verbruggen W; Schetz M; Verwaest C; Lauwers P; Bouillon R; Bowers CY
    J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of growth hormone-releasing peptide-2 (GHRP-2) and GH-releasing hormone (GHRH) on the the cAMP levels and GH release from cultured acromegalic tumours.
    Chen C; Pullar M; Loneragan K; Zhang J; Clarke IJ
    J Neuroendocrinol; 1998 Jun; 10(6):473-80. PubMed ID: 9688350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors.
    Goth MI; Lyons CE; Canny BJ; Thorner MO
    Endocrinology; 1992 Feb; 130(2):939-44. PubMed ID: 1346381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.